Kvåle Rune, Møller Bjørn, Wahlqvist Rolf, Fosså Sophie D, Berner Aasmund, Busch Christer, Kyrdalen Anne E, Svindland Aud, Viset Trond, Halvorsen Ole J
Department of Clinical and Registry-based Research, The Cancer Registry of Norway, Oslo, Norway.
BJU Int. 2009 Jun;103(12):1647-54. doi: 10.1111/j.1464-410X.2008.08255.x. Epub 2008 Dec 22.
To study the concordance between the Gleason scores of needle biopsies and radical prostatectomy (RP) specimens in a population-based registry, to clarify whether the concordance depends on the annual number of RP specimens assessed in the pathology unit, and to identify preoperative clinical factors that predict upgrading from a Gleason score of <or=6 in the biopsy to >or=7 in the RP specimen.
Through the Cancer Registry of Norway, we identified 1116 patients with available Gleason scores from biopsy and RP specimens. Concordance was evaluated using the kappa coefficient, and predictors of concordance were assessed in univariate and multivariate logistic regression analyses.
The Gleason scores were identical in biopsy and RP specimens in 591 of the 1116 (53%) patients. The biopsy-based Gleason score more often under-graded (38%) than over-graded (9%) the RP-based Gleason score. Pathology units that examined >40 RP specimens annually had a higher concordance between the Gleason score in the biopsy and RP specimen than did lower-volume units. The rate of upgrading from a Gleason score of <or=6 in the biopsy to >or=7 in the RP specimen increased with increasing preoperative prostate-specific antigen serum levels, and with increasing intervals between biopsy and RP.
The concordance in Gleason score between biopsy and RP was highest among the pathology departments that regularly evaluated RP specimens. Careful consideration of clinical factors and biopsy grading might improve the identification of patients considered as suitable for active surveillance.
在一项基于人群的登记研究中,探讨穿刺活检与根治性前列腺切除术(RP)标本的Gleason评分之间的一致性,阐明这种一致性是否取决于病理科每年评估的RP标本数量,并确定术前临床因素,以预测活检时Gleason评分为≤6分的患者在RP标本中是否会升级为≥7分。
通过挪威癌症登记处,我们确定了1116例有穿刺活检和RP标本Gleason评分的患者。使用kappa系数评估一致性,并在单因素和多因素逻辑回归分析中评估一致性的预测因素。
1116例患者中有591例(53%)的穿刺活检和RP标本Gleason评分相同。基于穿刺活检的Gleason评分对基于RP的Gleason评分进行低估(38%)的情况比高估(9%)更为常见。每年检查超过40例RP标本的病理科,其穿刺活检和RP标本的Gleason评分之间的一致性高于标本量较少的科室。穿刺活检时Gleason评分为≤6分的患者在RP标本中升级为≥7分的比例,随着术前前列腺特异性抗原血清水平的升高以及穿刺活检与RP之间间隔时间的延长而增加。
在定期评估RP标本的病理科中,穿刺活检和RP的Gleason评分一致性最高。仔细考虑临床因素和活检分级可能会改善对适合进行主动监测的患者的识别。